ArticleCancers2020

Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients.

Takashi Matsuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.